
Personalized medicine in development by type 2015
This statistic displays the percentage of personalized medicines in development by type as of 2015. In 2015, 42 percent of all drugs in development had the potential to be personalized medicines, while 73 percent of oncology drugs had the potential to be personalized medicines. Personalized medicines are medicines that, based on a patients biomarkers or biology, may be more a effective treatment option.